{
    "xml": "<topic id=\"PHP101780\" outputclass=\"drug\" rev=\"1.16\" type=\"drug\" namespace=\"/drugs/ibrutinib\" basename=\"ibrutinib\" title=\"IBRUTINIB\">\n<title>IBRUTINIB</title>\n<body>\r\n<p outputclass=\"interactionsLinks\"> List of individual interactants: <xref format=\"dita\" href=\"#bnf_int_1351\" namespace=\"/interactions/list-of-drug-interactions/cytotoxics/protein-kinase-inhibitors/ibrutinib\">Ibrutinib</xref>\n</p>\n<data name=\"vtmid\">28393111000001103</data>\n<data name=\"classifications\">\n<data name=\"classification\">\n<data name=\"drugClassification\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClassification\" href=\"#_208007314\" title=\"Protein kinase inhibitors\">Protein kinase inhibitors</xref>\n</data>\n</data>\n</data>\n<data name=\"primaryDomainOfEffect\">\n<data name=\"domainOfEffect\">  </data>\n</data>\r\n</body>\n<topic id=\"PHP101790\" outputclass=\"drugAction\" rev=\"1.8\" parent=\"/drugs/ibrutinib\">\n<title>Drug action</title>\n<body>\n<section>\n<sectiondiv>\n<p>Ibrutinib is a tyrosine kinase inhibitor.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP101793\" outputclass=\"indicationsAndDose\" rev=\"1.30\" parent=\"/drugs/ibrutinib\">\n<title>Indications and dose</title>\n<body>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Treatment of relapsed or refractory mantle cell lymphoma</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>560&#8239;mg once daily, for dose adjustments due to side effects consult product literature.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Treatment of chronic lymphocytic leukaemia, in patients who have received at least one prior therapy, or as first-line treatment in patients with 17p deletion or TP53 mutation who are unsuitable for chemo-immunotherapy</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>420&#8239;mg once daily, for dose adjustments due to side effects consult product literature.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Treatment of chronic lymphocytic leukaemia, in patients who have received at least one prior therapy, or as first-line treatment in patients with 17p deletion or TP53 mutation who are unsuitable for chemo-immunotherapy (patients taking concomitant moderate or potent CYP3A4 inhibitors)</p>\n<p outputclass=\"therapeuticIndication\">Treatment of relapsed or refractory mantle cell lymphoma (patients taking concomitant moderate or potent CYP3A4 inhibitors)</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>140&#8239;mg once daily, for dose adjustments due to side effects consult product literature.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"doseAdjustments\">\n<title>Dose adjustments due to interactions</title>\n<sectiondiv>\n<p>Reduce dose in patients taking concomitant potent CYP3A4 inhibitors (such as cobicistat, clarithromycin, darunavir boosted with ritonavir, indinavir, itraconazole, ketoconazole, ritonavir, saquinavir, telithromycin, and voriconazole) or moderate CYP3A4 inhibitors (such as amiodarone, aprepitant, atazanavir, ciprofloxacin, crizotinib, diltiazem, dronedarone, erythromycin, fluconazole, fosamprenavir, imatinib, and verapamil); alternatively temporarily stop ibrutinib if the potent CYP3A4 inhibitor is only required for 7 days or less. Avoid concomitant use with these drugs unless unavoidable.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP101789\" outputclass=\"importantSafetyInformation\" rev=\"1.8\" parent=\"/drugs/ibrutinib\">\n<title>Important safety information</title>\n<body>\n<section>\n<sectiondiv>\n<p outputclass=\"title\">Risks of incorrect dosing of oral anti-cancer medicines</p>\n<p>The National Patient Safety Agency has advised (January 2008) that the prescribing and use of oral cytotoxic medicines should be carried out to the same standard as parenteral cytotoxic therapy. Standards to be followed to achieve this include:</p>\n<ul>\n<li>non-specialists who prescribe or administer on-going oral cytotoxic medication should have access to written protocols and treatment plans, including guidance on the monitoring and treatment of toxicity</li>\n<li>staff dispensing oral cytotoxic medicines should confirm that the prescribed dose is appropriate for the patient. Patients should have written information that includes details of the intended oral anti-cancer regimen, the treatment plan, and arrangements for monitoring, taken from the original protocol from the initiating hospital. Staff dispensing oral cytotoxic medicines should also have access to this information, and to advice from an experienced cancer pharmacist in the initiating hospital</li>\n</ul>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP101786\" outputclass=\"cautions\" rev=\"1.23\" parent=\"/drugs/ibrutinib\">\n<title>Cautions</title>\n<body>\n<section outputclass=\"cautions\">\n<p>\n<ph outputclass=\"caution\">Family history of congenital short QT syndrome</ph>; <ph outputclass=\"caution\">increased lymphocytes&#8212;increased risk of leukostasis, consider withholding treatment temporarily and monitor closely</ph>; <ph outputclass=\"caution\">patients at risk from further shortening of QTc interval</ph>; <ph outputclass=\"caution\">personal history of congenital short QT syndrome</ph>; <ph outputclass=\"caution\">risk of haemorrhagic events&#8212;withhold ibrutinib treatment for at least 3 to 7 days before and after surgery depending on risk of bleeding</ph>\n</p>\n</section>\n</body>\n</topic>\n<topic id=\"PHP101794\" outputclass=\"interactions\" rev=\"1.21\" parent=\"/drugs/ibrutinib\">\n<title>Interactions</title>\n<body>\n<section outputclass=\"general\">\n<sectiondiv>\n<p>Appendix 1 (ibrutinib).</p>\n<p>Avoid concomitant use of drugs that increase risk of bleeding.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP101799\" outputclass=\"sideEffects\" rev=\"1.13\" parent=\"/drugs/ibrutinib\">\n<title>Side-effects</title>\n<body>\n<section outputclass=\"generalSideEffects\">\n<sectiondiv outputclass=\"frequencies\">\n<sectiondiv outputclass=\"commonOrVeryCommon\">\n<p outputclass=\"title\">Common or very common</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Arthralgia</ph>; <ph outputclass=\"sideEffect\">atrial fibrillation</ph>; <ph outputclass=\"sideEffect\">blurred vision</ph>; <ph outputclass=\"sideEffect\">bruising</ph>; <ph outputclass=\"sideEffect\">constipation</ph>; <ph outputclass=\"sideEffect\">dehydration</ph>; <ph outputclass=\"sideEffect\">diarrhoea</ph>; <ph outputclass=\"sideEffect\">dizziness</ph>; <ph outputclass=\"sideEffect\">dry mouth</ph>; <ph outputclass=\"sideEffect\">epistaxis</ph>; <ph outputclass=\"sideEffect\">haemorrhage</ph>; <ph outputclass=\"sideEffect\">headache</ph>; <ph outputclass=\"sideEffect\">musculoskeletal pain</ph>; <ph outputclass=\"sideEffect\">peripheral oedema</ph>; <ph outputclass=\"sideEffect\">petechiae</ph>; <ph outputclass=\"sideEffect\">pyrexia</ph>; <ph outputclass=\"sideEffect\">rash</ph>; <ph outputclass=\"sideEffect\">respiratory tract infection</ph>; <ph outputclass=\"sideEffect\">sepsis</ph>; <ph outputclass=\"sideEffect\">sinusitis</ph>; <ph outputclass=\"sideEffect\">skin infection</ph>; <ph outputclass=\"sideEffect\">subdural haematoma</ph>; <ph outputclass=\"sideEffect\">urinary tract infection</ph>\n</p>\n</sectiondiv>\n<sectiondiv outputclass=\"uncommon\">\n<p outputclass=\"title\">Uncommon</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Leukostasis</ph>\n</p>\n</sectiondiv>\n<sectiondiv outputclass=\"notKnown\">\n<p outputclass=\"title\">Frequency not known</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Alopecia</ph>; <ph outputclass=\"sideEffect\">bone-marrow suppression</ph>; <ph outputclass=\"sideEffect\">hyperuricaemia</ph>; <ph outputclass=\"sideEffect\">nausea</ph>; <ph outputclass=\"sideEffect\">oral mucositis</ph>; <ph outputclass=\"sideEffect\">thromboembolism</ph>; <ph outputclass=\"sideEffect\">tumour lysis syndrome</ph>; <ph outputclass=\"sideEffect\">vomiting</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP101787\" outputclass=\"conceptionAndContraception\" parent=\"/drugs/ibrutinib\">\n<title>Conception and contraception</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Exclude pregnancy before treatment with cytotoxic drugs.</p>\n<p>Contraceptive advice should be given to men and women before cytotoxic therapy begins (and should cover the duration of contraception required after therapy has ended).</p>\n<p>Highly effective contraception (must include a non-hormonal method) required during and for 3 months after stopping treatment.</p>\n<p>Regimens that do not contain an alkylating drug or procarbazine may have less effect on fertility, but those with an alkylating drug or procarbazine carry the risk of causing permanent male sterility (there is no effect on potency). Pretreatment counselling and consideration of sperm storage may be appropriate. Women are less severely affected, though the span of reproductive life may be shortened by the onset of a premature menopause. No increase in fetal abnormalities or abortion rate has been recorded in patients who remain fertile after cytotoxic chemotherapy.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP101795\" outputclass=\"pregnancy\" parent=\"/drugs/ibrutinib\">\n<title>Pregnancy</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Manufacturer advises avoid&#8212;toxicity in <i>animal</i> studies.</p>\n<p>Most cytotoxic drugs are teratogenic and should not be administered during pregnancy, especially during the first trimester. Considerable caution is necessary if a pregnant woman presents with cancer requiring chemotherapy, and specialist advice should always be sought.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP101785\" outputclass=\"breastFeeding\" parent=\"/drugs/ibrutinib\">\n<title>Breast feeding</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Manufacturer advises discontinue breastfeeding&#8212;no information available.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP101792\" outputclass=\"hepaticImpairment\" parent=\"/drugs/ibrutinib\">\n<title>Hepatic impairment</title>\n<body>\n<section outputclass=\"doseAdjustments\">\n<sectiondiv>\n<p>Reduce dose to 280&#8239;mg daily in mild impairment and reduce dose to 140&#8239;mg daily in moderate impairment&#8212;monitor for toxicity and adjust dose if necessary (consult product literature).</p>\n</sectiondiv>\n</section>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Avoid in severe impairment.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP101797\" outputclass=\"renalImpairment\" parent=\"/drugs/ibrutinib\">\n<title>Renal impairment</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Use in severe impairment only if benefit outweighs risk and with close monitoring for toxicity.</p>\n</sectiondiv>\n</section>\n<section outputclass=\"additionalMonitoringInRenalImpairment\">\n<sectiondiv>\n<p>Maintain hydration and monitor serum creatinine periodically in mild to moderate renal impairment.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP101803\" outputclass=\"monitoringRequirements\" parent=\"/drugs/ibrutinib\">\n<title>Monitoring requirements</title>\n<body>\n<section outputclass=\"monitoringOfPatientParameters\">\n<sectiondiv>\n<p>Monitor full blood count once a month.</p>\n<p>Monitor for atrial fibrillation (increased risk in cardiac risk factors, acute infections and history of atrial fibrillation), monitor all patients periodically and complete ECG if arrhythmic symptoms or dyspnoea develop&#8212;consult product literature for treatment options.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP101780-medicinalForms\" outputclass=\"medicinalForms\" parent=\"/drugs/ibrutinib\">\n<title>Medicinal forms</title>\n<body>\n<section outputclass=\"licensingVariationStatement\">\n<p>There can be variation in the licensing of different medicines containing the same drug.</p>\n</section>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"drugs\" href=\"#drugs\" title=\"Drugs\" namespace=\"/drugs\">Drugs</xref>\n</parents>\n<children>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP101864\" title=\"Capsule\" namespace=\"/drugs/ibrutinib/capsule\">Capsule</xref>\n</children>\n<backlinks>\n<xref format=\"dita\" scope=\"local\" type=\"drugClassifications\" href=\"#PHP106980\" namespace=\"/drug-classifications\" title=\"Drug classifications\" count=\"1\" rel=\"backlink\">Drug classifications</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#bnf_d1e85181\" href=\"#bnf_d1e85181\" namespace=\"/interactions/list-of-drug-interactions/aprepitant\" title=\"\" count=\"1\" rel=\"backlink\">bnf_d1e85181</xref>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_1010\" namespace=\"/interactions/list-of-drug-interactions/aprepitant\" title=\"Aprepitant\" count=\"1\" rel=\"backlink\">Aprepitant</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#bnf_d1e75236\" href=\"#bnf_d1e75236\" namespace=\"/interactions/list-of-drug-interactions/antivirals/atazanavir\" title=\"\" count=\"1\" rel=\"backlink\">bnf_d1e75236</xref>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_1005\" namespace=\"/interactions/list-of-drug-interactions/antivirals/atazanavir\" title=\"Atazanavir\" count=\"1\" rel=\"backlink\">Atazanavir</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#bnf_d1e72649\" href=\"#bnf_d1e72649\" namespace=\"/interactions/list-of-drug-interactions/antivirals/fosamprenavir\" title=\"\" count=\"1\" rel=\"backlink\">bnf_d1e72649</xref>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_1019\" namespace=\"/interactions/list-of-drug-interactions/antivirals/fosamprenavir\" title=\"Fosamprenavir\" count=\"1\" rel=\"backlink\">Fosamprenavir</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#bnf_d1e73765\" href=\"#bnf_d1e73765\" namespace=\"/interactions/list-of-drug-interactions/antivirals/darunavir\" title=\"\" count=\"1\" rel=\"backlink\">bnf_d1e73765</xref>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_1091\" namespace=\"/interactions/list-of-drug-interactions/antivirals/darunavir\" title=\"Darunavir\" count=\"1\" rel=\"backlink\">Darunavir</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#bnf_d1e11129\" href=\"#bnf_d1e11129\" namespace=\"/interactions/list-of-drug-interactions/anti-arrhythmics/dronedarone\" title=\"\" count=\"1\" rel=\"backlink\">bnf_d1e11129</xref>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_1176\" namespace=\"/interactions/list-of-drug-interactions/anti-arrhythmics/dronedarone\" title=\"Dronedarone\" count=\"1\" rel=\"backlink\">Dronedarone</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#bnf_d1e12200\" href=\"#bnf_d1e12200\" namespace=\"/interactions/list-of-drug-interactions/anti-arrhythmics/amiodarone\" title=\"\" count=\"1\" rel=\"backlink\">bnf_d1e12200</xref>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_118\" namespace=\"/interactions/list-of-drug-interactions/anti-arrhythmics/amiodarone\" title=\"Amiodarone\" count=\"1\" rel=\"backlink\">Amiodarone</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#bnf_d1e102197\" href=\"#bnf_d1e102197\" namespace=\"/interactions/list-of-drug-interactions/cytotoxics/protein-kinase-inhibitors/crizotinib\" title=\"\" count=\"1\" rel=\"backlink\">bnf_d1e102197</xref>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_1240\" namespace=\"/interactions/list-of-drug-interactions/cytotoxics/protein-kinase-inhibitors/crizotinib\" title=\"Crizotinib\" count=\"1\" rel=\"backlink\">Crizotinib</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#bnf_d1e96354\" href=\"#bnf_d1e96354\" namespace=\"/interactions/list-of-drug-interactions/cobicistat\" title=\"\" count=\"1\" rel=\"backlink\">bnf_d1e96354</xref>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_1259\" namespace=\"/interactions/list-of-drug-interactions/cobicistat\" title=\"Cobicistat\" count=\"1\" rel=\"backlink\">Cobicistat</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#bnf_d1e99337\" href=\"#bnf_d1e99337\" namespace=\"/interactions/list-of-drug-interactions/cytotoxics/protein-kinase-inhibitors/ibrutinib\" title=\"\" count=\"1\" rel=\"backlink\">bnf_d1e99337</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#bnf_d1e99360\" href=\"#bnf_d1e99360\" namespace=\"/interactions/list-of-drug-interactions/cytotoxics/protein-kinase-inhibitors/ibrutinib\" title=\"\" count=\"1\" rel=\"backlink\">bnf_d1e99360</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#bnf_d1e99383\" href=\"#bnf_d1e99383\" namespace=\"/interactions/list-of-drug-interactions/cytotoxics/protein-kinase-inhibitors/ibrutinib\" title=\"\" count=\"1\" rel=\"backlink\">bnf_d1e99383</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#bnf_d1e99423\" href=\"#bnf_d1e99423\" namespace=\"/interactions/list-of-drug-interactions/cytotoxics/protein-kinase-inhibitors/ibrutinib\" title=\"\" count=\"1\" rel=\"backlink\">bnf_d1e99423</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#bnf_d1e99446\" href=\"#bnf_d1e99446\" namespace=\"/interactions/list-of-drug-interactions/cytotoxics/protein-kinase-inhibitors/ibrutinib\" title=\"\" count=\"1\" rel=\"backlink\">bnf_d1e99446</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#bnf_d1e99469\" href=\"#bnf_d1e99469\" namespace=\"/interactions/list-of-drug-interactions/cytotoxics/protein-kinase-inhibitors/ibrutinib\" title=\"\" count=\"1\" rel=\"backlink\">bnf_d1e99469</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#bnf_d1e99505\" href=\"#bnf_d1e99505\" namespace=\"/interactions/list-of-drug-interactions/cytotoxics/protein-kinase-inhibitors/ibrutinib\" title=\"\" count=\"1\" rel=\"backlink\">bnf_d1e99505</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#bnf_d1e99528\" href=\"#bnf_d1e99528\" namespace=\"/interactions/list-of-drug-interactions/cytotoxics/protein-kinase-inhibitors/ibrutinib\" title=\"\" count=\"1\" rel=\"backlink\">bnf_d1e99528</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#bnf_d1e99568\" href=\"#bnf_d1e99568\" namespace=\"/interactions/list-of-drug-interactions/cytotoxics/protein-kinase-inhibitors/ibrutinib\" title=\"\" count=\"1\" rel=\"backlink\">bnf_d1e99568</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#bnf_d1e99591\" href=\"#bnf_d1e99591\" namespace=\"/interactions/list-of-drug-interactions/cytotoxics/protein-kinase-inhibitors/ibrutinib\" title=\"\" count=\"1\" rel=\"backlink\">bnf_d1e99591</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#bnf_d1e99614\" href=\"#bnf_d1e99614\" namespace=\"/interactions/list-of-drug-interactions/cytotoxics/protein-kinase-inhibitors/ibrutinib\" title=\"\" count=\"1\" rel=\"backlink\">bnf_d1e99614</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#bnf_d1e99637\" href=\"#bnf_d1e99637\" namespace=\"/interactions/list-of-drug-interactions/cytotoxics/protein-kinase-inhibitors/ibrutinib\" title=\"\" count=\"1\" rel=\"backlink\">bnf_d1e99637</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#bnf_d1e99660\" href=\"#bnf_d1e99660\" namespace=\"/interactions/list-of-drug-interactions/cytotoxics/protein-kinase-inhibitors/ibrutinib\" title=\"\" count=\"1\" rel=\"backlink\">bnf_d1e99660</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#bnf_d1e99726\" href=\"#bnf_d1e99726\" namespace=\"/interactions/list-of-drug-interactions/cytotoxics/protein-kinase-inhibitors/ibrutinib\" title=\"\" count=\"1\" rel=\"backlink\">bnf_d1e99726</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#bnf_d1e99749\" href=\"#bnf_d1e99749\" namespace=\"/interactions/list-of-drug-interactions/cytotoxics/protein-kinase-inhibitors/ibrutinib\" title=\"\" count=\"1\" rel=\"backlink\">bnf_d1e99749</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#bnf_d1e99772\" href=\"#bnf_d1e99772\" namespace=\"/interactions/list-of-drug-interactions/cytotoxics/protein-kinase-inhibitors/ibrutinib\" title=\"\" count=\"1\" rel=\"backlink\">bnf_d1e99772</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#bnf_d1e99796\" href=\"#bnf_d1e99796\" namespace=\"/interactions/list-of-drug-interactions/cytotoxics/protein-kinase-inhibitors/ibrutinib\" title=\"\" count=\"1\" rel=\"backlink\">bnf_d1e99796</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#bnf_d1e99863\" href=\"#bnf_d1e99863\" namespace=\"/interactions/list-of-drug-interactions/cytotoxics/protein-kinase-inhibitors/ibrutinib\" title=\"\" count=\"1\" rel=\"backlink\">bnf_d1e99863</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#bnf_d1e99886\" href=\"#bnf_d1e99886\" namespace=\"/interactions/list-of-drug-interactions/cytotoxics/protein-kinase-inhibitors/ibrutinib\" title=\"\" count=\"1\" rel=\"backlink\">bnf_d1e99886</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#bnf_d1e99926\" href=\"#bnf_d1e99926\" namespace=\"/interactions/list-of-drug-interactions/cytotoxics/protein-kinase-inhibitors/ibrutinib\" title=\"\" count=\"1\" rel=\"backlink\">bnf_d1e99926</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#bnf_d1e99949\" href=\"#bnf_d1e99949\" namespace=\"/interactions/list-of-drug-interactions/cytotoxics/protein-kinase-inhibitors/ibrutinib\" title=\"\" count=\"1\" rel=\"backlink\">bnf_d1e99949</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#bnf_d1e99985\" href=\"#bnf_d1e99985\" namespace=\"/interactions/list-of-drug-interactions/cytotoxics/protein-kinase-inhibitors/ibrutinib\" title=\"\" count=\"1\" rel=\"backlink\">bnf_d1e99985</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#bnf_d1e53654\" href=\"#bnf_d1e53654\" namespace=\"/interactions/list-of-drug-interactions/antifungals/antifungals-imidazole/ketoconazole\" title=\"\" count=\"1\" rel=\"backlink\">bnf_d1e53654</xref>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_1365\" namespace=\"/interactions/list-of-drug-interactions/antifungals/antifungals-imidazole/ketoconazole\" title=\"Ketoconazole\" count=\"1\" rel=\"backlink\">Ketoconazole</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#bnf_d1e18111\" href=\"#bnf_d1e18111\" namespace=\"/interactions/list-of-drug-interactions/antibacterials/macrolides/clarithromycin\" title=\"\" count=\"1\" rel=\"backlink\">bnf_d1e18111</xref>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_168\" namespace=\"/interactions/list-of-drug-interactions/antibacterials/macrolides/clarithromycin\" title=\"Clarithromycin\" count=\"1\" rel=\"backlink\">Clarithromycin</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#bnf_d1e19461\" href=\"#bnf_d1e19461\" namespace=\"/interactions/list-of-drug-interactions/antibacterials/macrolides/erythromycin\" title=\"\" count=\"1\" rel=\"backlink\">bnf_d1e19461</xref>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_169\" namespace=\"/interactions/list-of-drug-interactions/antibacterials/macrolides/erythromycin\" title=\"Erythromycin\" count=\"1\" rel=\"backlink\">Erythromycin</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#bnf_d1e21588\" href=\"#bnf_d1e21588\" namespace=\"/interactions/list-of-drug-interactions/antibacterials/quinolones/ciprofloxacin\" title=\"\" count=\"1\" rel=\"backlink\">bnf_d1e21588</xref>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_195\" namespace=\"/interactions/list-of-drug-interactions/antibacterials/quinolones/ciprofloxacin\" title=\"Ciprofloxacin\" count=\"1\" rel=\"backlink\">Ciprofloxacin</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#bnf_d1e56961\" href=\"#bnf_d1e56961\" namespace=\"/interactions/list-of-drug-interactions/antifungals/antifungals-triazole/fluconazole\" title=\"\" count=\"1\" rel=\"backlink\">bnf_d1e56961</xref>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_301\" namespace=\"/interactions/list-of-drug-interactions/antifungals/antifungals-triazole/fluconazole\" title=\"Fluconazole\" count=\"1\" rel=\"backlink\">Fluconazole</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#bnf_d1e58166\" href=\"#bnf_d1e58166\" namespace=\"/interactions/list-of-drug-interactions/antifungals/antifungals-triazole/itraconazole\" title=\"\" count=\"1\" rel=\"backlink\">bnf_d1e58166</xref>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_302\" namespace=\"/interactions/list-of-drug-interactions/antifungals/antifungals-triazole/itraconazole\" title=\"Itraconazole\" count=\"1\" rel=\"backlink\">Itraconazole</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#bnf_d1e77639\" href=\"#bnf_d1e77639\" namespace=\"/interactions/list-of-drug-interactions/antivirals/indinavir\" title=\"\" count=\"1\" rel=\"backlink\">bnf_d1e77639</xref>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_398\" namespace=\"/interactions/list-of-drug-interactions/antivirals/indinavir\" title=\"Indinavir\" count=\"1\" rel=\"backlink\">Indinavir</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#bnf_d1e80257\" href=\"#bnf_d1e80257\" namespace=\"/interactions/list-of-drug-interactions/antivirals/ritonavir\" title=\"\" count=\"1\" rel=\"backlink\">bnf_d1e80257</xref>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_400\" namespace=\"/interactions/list-of-drug-interactions/antivirals/ritonavir\" title=\"Ritonavir\" count=\"1\" rel=\"backlink\">Ritonavir</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#bnf_d1e90830\" href=\"#bnf_d1e90830\" namespace=\"/interactions/list-of-drug-interactions/calcium-channel-blockers/verapamil\" title=\"\" count=\"1\" rel=\"backlink\">bnf_d1e90830</xref>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_467\" namespace=\"/interactions/list-of-drug-interactions/calcium-channel-blockers/verapamil\" title=\"Verapamil\" count=\"1\" rel=\"backlink\">Verapamil</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#bnf_d1e90036\" href=\"#bnf_d1e90036\" namespace=\"/interactions/list-of-drug-interactions/calcium-channel-blockers/diltiazem\" title=\"\" count=\"1\" rel=\"backlink\">bnf_d1e90036</xref>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_468\" namespace=\"/interactions/list-of-drug-interactions/calcium-channel-blockers/diltiazem\" title=\"Diltiazem\" count=\"1\" rel=\"backlink\">Diltiazem</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#bnf_d1e81849\" href=\"#bnf_d1e81849\" namespace=\"/interactions/list-of-drug-interactions/antivirals/saquinavir\" title=\"\" count=\"1\" rel=\"backlink\">bnf_d1e81849</xref>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_791\" namespace=\"/interactions/list-of-drug-interactions/antivirals/saquinavir\" title=\"Saquinavir\" count=\"1\" rel=\"backlink\">Saquinavir</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#bnf_d1e105191\" href=\"#bnf_d1e105191\" namespace=\"/interactions/list-of-drug-interactions/cytotoxics/protein-kinase-inhibitors/imatinib\" title=\"\" count=\"1\" rel=\"backlink\">bnf_d1e105191</xref>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_933\" namespace=\"/interactions/list-of-drug-interactions/cytotoxics/protein-kinase-inhibitors/imatinib\" title=\"Imatinib\" count=\"1\" rel=\"backlink\">Imatinib</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#bnf_d1e15531\" href=\"#bnf_d1e15531\" namespace=\"/interactions/list-of-drug-interactions/antibacterials/telithromycin\" title=\"\" count=\"1\" rel=\"backlink\">bnf_d1e15531</xref>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_946\" namespace=\"/interactions/list-of-drug-interactions/antibacterials/telithromycin\" title=\"Telithromycin\" count=\"1\" rel=\"backlink\">Telithromycin</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#bnf_d1e56135\" href=\"#bnf_d1e56135\" namespace=\"/interactions/list-of-drug-interactions/antifungals/antifungals-triazole/voriconazole\" title=\"\" count=\"1\" rel=\"backlink\">bnf_d1e56135</xref>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_948\" namespace=\"/interactions/list-of-drug-interactions/antifungals/antifungals-triazole/voriconazole\" title=\"Voriconazole\" count=\"1\" rel=\"backlink\">Voriconazole</xref>\n</backlinks>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_1351\" namespace=\"/interactions/list-of-drug-interactions/cytotoxics/protein-kinase-inhibitors/ibrutinib\" title=\"Ibrutinib\" count=\"1\" rel=\"link\">Ibrutinib</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#drugs\" href=\"#drugs\" namespace=\"/drugs\" title=\"Drugs\" count=\"1\" rel=\"link\">Drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP101864\" namespace=\"/drugs/ibrutinib/capsule\" title=\"Capsule\" count=\"1\" rel=\"link\">Capsule</xref>\n</links>\n</topic>",
    "id": "PHP101780",
    "outputclass": "drug",
    "rev": "1.16",
    "type": "drug",
    "namespace": "/drugs/ibrutinib",
    "basename": "ibrutinib",
    "title": "IBRUTINIB",
    "interactants": [
        {
            "id": "bnf_int_1351",
            "label": "Ibrutinib"
        }
    ],
    "vtmid": "28393111000001103",
    "drugClassification": [
        "Protein kinase inhibitors"
    ],
    "primaryDomainOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "drugAction": {
        "drugAction": [
            {
                "type": "drugAction",
                "textContent": "Ibrutinib is a tyrosine kinase inhibitor.",
                "html": "<p>Ibrutinib is a tyrosine kinase inhibitor.</p>"
            }
        ]
    },
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [
            {
                "indications": [
                    {
                        "textContent": "Treatment of relapsed or refractory mantle cell lymphoma",
                        "html": "Treatment of relapsed or refractory mantle cell lymphoma"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "560 mg once daily, for dose adjustments due to side effects consult product literature.",
                        "html": "<p>560&#8239;mg once daily, for dose adjustments due to side effects consult product literature.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Treatment of chronic lymphocytic leukaemia, in patients who have received at least one prior therapy, or as first-line treatment in patients with 17p deletion or TP53 mutation who are unsuitable for chemo-immunotherapy",
                        "html": "Treatment of chronic lymphocytic leukaemia, in patients who have received at least one prior therapy, or as first-line treatment in patients with 17p deletion or TP53 mutation who are unsuitable for chemo-immunotherapy"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "420 mg once daily, for dose adjustments due to side effects consult product literature.",
                        "html": "<p>420&#8239;mg once daily, for dose adjustments due to side effects consult product literature.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Treatment of chronic lymphocytic leukaemia, in patients who have received at least one prior therapy, or as first-line treatment in patients with 17p deletion or TP53 mutation who are unsuitable for chemo-immunotherapy (patients taking concomitant moderate or potent CYP3A4 inhibitors)",
                        "html": "Treatment of chronic lymphocytic leukaemia, in patients who have received at least one prior therapy, or as first-line treatment in patients with 17p deletion or TP53 mutation who are unsuitable for chemo-immunotherapy (patients taking concomitant moderate or potent CYP3A4 inhibitors)"
                    },
                    {
                        "textContent": "Treatment of relapsed or refractory mantle cell lymphoma (patients taking concomitant moderate or potent CYP3A4 inhibitors)",
                        "html": "Treatment of relapsed or refractory mantle cell lymphoma (patients taking concomitant moderate or potent CYP3A4 inhibitors)"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "140 mg once daily, for dose adjustments due to side effects consult product literature.",
                        "html": "<p>140&#8239;mg once daily, for dose adjustments due to side effects consult product literature.</p>"
                    }
                ]
            }
        ],
        "doseAdjustments": [
            {
                "type": "doseAdjustments",
                "title": "Dose adjustments due to interactions",
                "textContent": "Reduce dose in patients taking concomitant potent CYP3A4 inhibitors (such as cobicistat, clarithromycin, darunavir boosted with ritonavir, indinavir, itraconazole, ketoconazole, ritonavir, saquinavir, telithromycin, and voriconazole) or moderate CYP3A4 inhibitors (such as amiodarone, aprepitant, atazanavir, ciprofloxacin, crizotinib, diltiazem, dronedarone, erythromycin, fluconazole, fosamprenavir, imatinib, and verapamil); alternatively temporarily stop ibrutinib if the potent CYP3A4 inhibitor is only required for 7 days or less. Avoid concomitant use with these drugs unless unavoidable.",
                "html": "<p>Reduce dose in patients taking concomitant potent CYP3A4 inhibitors (such as cobicistat, clarithromycin, darunavir boosted with ritonavir, indinavir, itraconazole, ketoconazole, ritonavir, saquinavir, telithromycin, and voriconazole) or moderate CYP3A4 inhibitors (such as amiodarone, aprepitant, atazanavir, ciprofloxacin, crizotinib, diltiazem, dronedarone, erythromycin, fluconazole, fosamprenavir, imatinib, and verapamil); alternatively temporarily stop ibrutinib if the potent CYP3A4 inhibitor is only required for 7 days or less. Avoid concomitant use with these drugs unless unavoidable.</p>"
            }
        ]
    },
    "importantSafetyInformation": {
        "importantSafetyInformation": [
            {
                "type": "importantSafetyInformation",
                "title": "Risks of incorrect dosing of oral anti-cancer medicines",
                "textContent": "The National Patient Safety Agency has advised (January 2008) that the prescribing and use of oral cytotoxic medicines should be carried out to the same standard as parenteral cytotoxic therapy. Standards to be followed to achieve this include:\n\nnon-specialists who prescribe or administer on-going oral cytotoxic medication should have access to written protocols and treatment plans, including guidance on the monitoring and treatment of toxicity staff dispensing oral cytotoxic medicines should confirm that the prescribed dose is appropriate for the patient. Patients should have written information that includes details of the intended oral anti-cancer regimen, the treatment plan, and arrangements for monitoring, taken from the original protocol from the initiating hospital. Staff dispensing oral cytotoxic medicines should also have access to this information, and to advice from an experienced cancer pharmacist in the initiating hospital",
                "html": "<p>The National Patient Safety Agency has advised (January 2008) that the prescribing and use of oral cytotoxic medicines should be carried out to the same standard as parenteral cytotoxic therapy. Standards to be followed to achieve this include:</p><ul>\n<li>non-specialists who prescribe or administer on-going oral cytotoxic medication should have access to written protocols and treatment plans, including guidance on the monitoring and treatment of toxicity</li>\n<li>staff dispensing oral cytotoxic medicines should confirm that the prescribed dose is appropriate for the patient. Patients should have written information that includes details of the intended oral anti-cancer regimen, the treatment plan, and arrangements for monitoring, taken from the original protocol from the initiating hospital. Staff dispensing oral cytotoxic medicines should also have access to this information, and to advice from an experienced cancer pharmacist in the initiating hospital</li>\n</ul>"
            }
        ]
    },
    "cautions": {
        "cautions": [
            {
                "type": "cautions",
                "textContent": "Family history of congenital short QT syndrome",
                "html": "Family history of congenital short QT syndrome"
            },
            {
                "type": "cautions",
                "textContent": "increased lymphocytes&#8212;increased risk of leukostasis, consider withholding treatment temporarily and monitor closely",
                "html": "increased lymphocytes&#8212;increased risk of leukostasis, consider withholding treatment temporarily and monitor closely"
            },
            {
                "type": "cautions",
                "textContent": "patients at risk from further shortening of QTc interval",
                "html": "patients at risk from further shortening of QTc interval"
            },
            {
                "type": "cautions",
                "textContent": "personal history of congenital short QT syndrome",
                "html": "personal history of congenital short QT syndrome"
            },
            {
                "type": "cautions",
                "textContent": "risk of haemorrhagic events&#8212;withhold ibrutinib treatment for at least 3 to 7 days before and after surgery depending on risk of bleeding",
                "html": "risk of haemorrhagic events&#8212;withhold ibrutinib treatment for at least 3 to 7 days before and after surgery depending on risk of bleeding"
            }
        ]
    },
    "interactions": {
        "general": [
            {
                "type": "general",
                "textContent": "Appendix 1 (ibrutinib).\n\nAvoid concomitant use of drugs that increase risk of bleeding.",
                "html": "<p>Appendix 1 (ibrutinib).</p><p>Avoid concomitant use of drugs that increase risk of bleeding.</p>"
            }
        ]
    },
    "sideEffects": {
        "general": {
            "frequencies": {
                "commonOrVeryCommon": [
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "Arthralgia",
                        "html": "Arthralgia",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "atrial fibrillation",
                        "html": "atrial fibrillation",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "blurred vision",
                        "html": "blurred vision",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "bruising",
                        "html": "bruising",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "constipation",
                        "html": "constipation",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "dehydration",
                        "html": "dehydration",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "diarrhoea",
                        "html": "diarrhoea",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "dizziness",
                        "html": "dizziness",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "dry mouth",
                        "html": "dry mouth",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "epistaxis",
                        "html": "epistaxis",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "haemorrhage",
                        "html": "haemorrhage",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "headache",
                        "html": "headache",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "musculoskeletal pain",
                        "html": "musculoskeletal pain",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "peripheral oedema",
                        "html": "peripheral oedema",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "petechiae",
                        "html": "petechiae",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "pyrexia",
                        "html": "pyrexia",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "rash",
                        "html": "rash",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "respiratory tract infection",
                        "html": "respiratory tract infection",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "sepsis",
                        "html": "sepsis",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "sinusitis",
                        "html": "sinusitis",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "skin infection",
                        "html": "skin infection",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "subdural haematoma",
                        "html": "subdural haematoma",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "urinary tract infection",
                        "html": "urinary tract infection",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    }
                ],
                "uncommon": [
                    {
                        "type": "uncommon",
                        "textContent": "Leukostasis",
                        "html": "Leukostasis",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    }
                ],
                "notKnown": [
                    {
                        "type": "notKnown",
                        "textContent": "Alopecia",
                        "html": "Alopecia",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "bone-marrow suppression",
                        "html": "bone-marrow suppression",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "hyperuricaemia",
                        "html": "hyperuricaemia",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "nausea",
                        "html": "nausea",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "oral mucositis",
                        "html": "oral mucositis",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "thromboembolism",
                        "html": "thromboembolism",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "tumour lysis syndrome",
                        "html": "tumour lysis syndrome",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "vomiting",
                        "html": "vomiting",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    }
                ]
            }
        }
    },
    "conceptionAndContraception": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Exclude pregnancy before treatment with cytotoxic drugs.\n\nContraceptive advice should be given to men and women before cytotoxic therapy begins (and should cover the duration of contraception required after therapy has ended).\n\nHighly effective contraception (must include a non-hormonal method) required during and for 3 months after stopping treatment.\n\nRegimens that do not contain an alkylating drug or procarbazine may have less effect on fertility, but those with an alkylating drug or procarbazine carry the risk of causing permanent male sterility (there is no effect on potency). Pretreatment counselling and consideration of sperm storage may be appropriate. Women are less severely affected, though the span of reproductive life may be shortened by the onset of a premature menopause. No increase in fetal abnormalities or abortion rate has been recorded in patients who remain fertile after cytotoxic chemotherapy.",
                "html": "<p>Exclude pregnancy before treatment with cytotoxic drugs.</p><p>Contraceptive advice should be given to men and women before cytotoxic therapy begins (and should cover the duration of contraception required after therapy has ended).</p><p>Highly effective contraception (must include a non-hormonal method) required during and for 3 months after stopping treatment.</p><p>Regimens that do not contain an alkylating drug or procarbazine may have less effect on fertility, but those with an alkylating drug or procarbazine carry the risk of causing permanent male sterility (there is no effect on potency). Pretreatment counselling and consideration of sperm storage may be appropriate. Women are less severely affected, though the span of reproductive life may be shortened by the onset of a premature menopause. No increase in fetal abnormalities or abortion rate has been recorded in patients who remain fertile after cytotoxic chemotherapy.</p>"
            }
        ]
    },
    "pregnancy": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Manufacturer advises avoid&#8212;toxicity in animal studies.\n\nMost cytotoxic drugs are teratogenic and should not be administered during pregnancy, especially during the first trimester. Considerable caution is necessary if a pregnant woman presents with cancer requiring chemotherapy, and specialist advice should always be sought.",
                "html": "<p>Manufacturer advises avoid&#8212;toxicity in <i>animal</i> studies.</p><p>Most cytotoxic drugs are teratogenic and should not be administered during pregnancy, especially during the first trimester. Considerable caution is necessary if a pregnant woman presents with cancer requiring chemotherapy, and specialist advice should always be sought.</p>"
            }
        ]
    },
    "breastFeeding": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Manufacturer advises discontinue breastfeeding&#8212;no information available.",
                "html": "<p>Manufacturer advises discontinue breastfeeding&#8212;no information available.</p>"
            }
        ]
    },
    "hepaticImpairment": {
        "doseAdjustments": [
            {
                "type": "doseAdjustments",
                "textContent": "Reduce dose to 280 mg daily in mild impairment and reduce dose to 140 mg daily in moderate impairment&#8212;monitor for toxicity and adjust dose if necessary (consult product literature).",
                "html": "<p>Reduce dose to 280&#8239;mg daily in mild impairment and reduce dose to 140&#8239;mg daily in moderate impairment&#8212;monitor for toxicity and adjust dose if necessary (consult product literature).</p>"
            }
        ],
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Avoid in severe impairment.",
                "html": "<p>Avoid in severe impairment.</p>"
            }
        ]
    },
    "renalImpairment": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Use in severe impairment only if benefit outweighs risk and with close monitoring for toxicity.",
                "html": "<p>Use in severe impairment only if benefit outweighs risk and with close monitoring for toxicity.</p>"
            }
        ],
        "additionalMonitoring": [
            {
                "type": "additionalMonitoring",
                "textContent": "Maintain hydration and monitor serum creatinine periodically in mild to moderate renal impairment.",
                "html": "<p>Maintain hydration and monitor serum creatinine periodically in mild to moderate renal impairment.</p>"
            }
        ]
    },
    "monitoringRequirements": {
        "patientParameters": [
            {
                "type": "patientParameters",
                "textContent": "Monitor full blood count once a month.\n\nMonitor for atrial fibrillation (increased risk in cardiac risk factors, acute infections and history of atrial fibrillation), monitor all patients periodically and complete ECG if arrhythmic symptoms or dyspnoea develop&#8212;consult product literature for treatment options.",
                "html": "<p>Monitor full blood count once a month.</p><p>Monitor for atrial fibrillation (increased risk in cardiac risk factors, acute infections and history of atrial fibrillation), monitor all patients periodically and complete ECG if arrhythmic symptoms or dyspnoea develop&#8212;consult product literature for treatment options.</p>"
            }
        ]
    },
    "medicinalForms": {
        "licensingVariationStatement": [
            {
                "type": "licensingVariationStatement",
                "textContent": "There can be variation in the licensing of different medicines containing the same drug.",
                "html": "<p>There can be variation in the licensing of different medicines containing the same drug.</p>"
            }
        ]
    },
    "children": {
        "medicinalForm": [
            {
                "id": "PHP101864",
                "label": "Capsule",
                "type": "medicinalForm"
            }
        ]
    },
    "backlinks": {
        "drugClassifications": [
            {
                "id": "PHP106980",
                "label": "Drug classifications",
                "type": "drugClassifications"
            }
        ],
        "#bnf_d1e85181": [
            {
                "id": "bnf_d1e85181",
                "label": "bnf_d1e85181",
                "type": "#bnf_d1e85181"
            }
        ],
        "interaction": [
            {
                "id": "bnf_int_1010",
                "label": "Aprepitant",
                "type": "interaction"
            },
            {
                "id": "bnf_int_1005",
                "label": "Atazanavir",
                "type": "interaction"
            },
            {
                "id": "bnf_int_1019",
                "label": "Fosamprenavir",
                "type": "interaction"
            },
            {
                "id": "bnf_int_1091",
                "label": "Darunavir",
                "type": "interaction"
            },
            {
                "id": "bnf_int_1176",
                "label": "Dronedarone",
                "type": "interaction"
            },
            {
                "id": "bnf_int_118",
                "label": "Amiodarone",
                "type": "interaction"
            },
            {
                "id": "bnf_int_1240",
                "label": "Crizotinib",
                "type": "interaction"
            },
            {
                "id": "bnf_int_1259",
                "label": "Cobicistat",
                "type": "interaction"
            },
            {
                "id": "bnf_int_1365",
                "label": "Ketoconazole",
                "type": "interaction"
            },
            {
                "id": "bnf_int_168",
                "label": "Clarithromycin",
                "type": "interaction"
            },
            {
                "id": "bnf_int_169",
                "label": "Erythromycin",
                "type": "interaction"
            },
            {
                "id": "bnf_int_195",
                "label": "Ciprofloxacin",
                "type": "interaction"
            },
            {
                "id": "bnf_int_301",
                "label": "Fluconazole",
                "type": "interaction"
            },
            {
                "id": "bnf_int_302",
                "label": "Itraconazole",
                "type": "interaction"
            },
            {
                "id": "bnf_int_398",
                "label": "Indinavir",
                "type": "interaction"
            },
            {
                "id": "bnf_int_400",
                "label": "Ritonavir",
                "type": "interaction"
            },
            {
                "id": "bnf_int_467",
                "label": "Verapamil",
                "type": "interaction"
            },
            {
                "id": "bnf_int_468",
                "label": "Diltiazem",
                "type": "interaction"
            },
            {
                "id": "bnf_int_791",
                "label": "Saquinavir",
                "type": "interaction"
            },
            {
                "id": "bnf_int_933",
                "label": "Imatinib",
                "type": "interaction"
            },
            {
                "id": "bnf_int_946",
                "label": "Telithromycin",
                "type": "interaction"
            },
            {
                "id": "bnf_int_948",
                "label": "Voriconazole",
                "type": "interaction"
            }
        ],
        "#bnf_d1e75236": [
            {
                "id": "bnf_d1e75236",
                "label": "bnf_d1e75236",
                "type": "#bnf_d1e75236"
            }
        ],
        "#bnf_d1e72649": [
            {
                "id": "bnf_d1e72649",
                "label": "bnf_d1e72649",
                "type": "#bnf_d1e72649"
            }
        ],
        "#bnf_d1e73765": [
            {
                "id": "bnf_d1e73765",
                "label": "bnf_d1e73765",
                "type": "#bnf_d1e73765"
            }
        ],
        "#bnf_d1e11129": [
            {
                "id": "bnf_d1e11129",
                "label": "bnf_d1e11129",
                "type": "#bnf_d1e11129"
            }
        ],
        "#bnf_d1e12200": [
            {
                "id": "bnf_d1e12200",
                "label": "bnf_d1e12200",
                "type": "#bnf_d1e12200"
            }
        ],
        "#bnf_d1e102197": [
            {
                "id": "bnf_d1e102197",
                "label": "bnf_d1e102197",
                "type": "#bnf_d1e102197"
            }
        ],
        "#bnf_d1e96354": [
            {
                "id": "bnf_d1e96354",
                "label": "bnf_d1e96354",
                "type": "#bnf_d1e96354"
            }
        ],
        "#bnf_d1e99337": [
            {
                "id": "bnf_d1e99337",
                "label": "bnf_d1e99337",
                "type": "#bnf_d1e99337"
            }
        ],
        "#bnf_d1e99360": [
            {
                "id": "bnf_d1e99360",
                "label": "bnf_d1e99360",
                "type": "#bnf_d1e99360"
            }
        ],
        "#bnf_d1e99383": [
            {
                "id": "bnf_d1e99383",
                "label": "bnf_d1e99383",
                "type": "#bnf_d1e99383"
            }
        ],
        "#bnf_d1e99423": [
            {
                "id": "bnf_d1e99423",
                "label": "bnf_d1e99423",
                "type": "#bnf_d1e99423"
            }
        ],
        "#bnf_d1e99446": [
            {
                "id": "bnf_d1e99446",
                "label": "bnf_d1e99446",
                "type": "#bnf_d1e99446"
            }
        ],
        "#bnf_d1e99469": [
            {
                "id": "bnf_d1e99469",
                "label": "bnf_d1e99469",
                "type": "#bnf_d1e99469"
            }
        ],
        "#bnf_d1e99505": [
            {
                "id": "bnf_d1e99505",
                "label": "bnf_d1e99505",
                "type": "#bnf_d1e99505"
            }
        ],
        "#bnf_d1e99528": [
            {
                "id": "bnf_d1e99528",
                "label": "bnf_d1e99528",
                "type": "#bnf_d1e99528"
            }
        ],
        "#bnf_d1e99568": [
            {
                "id": "bnf_d1e99568",
                "label": "bnf_d1e99568",
                "type": "#bnf_d1e99568"
            }
        ],
        "#bnf_d1e99591": [
            {
                "id": "bnf_d1e99591",
                "label": "bnf_d1e99591",
                "type": "#bnf_d1e99591"
            }
        ],
        "#bnf_d1e99614": [
            {
                "id": "bnf_d1e99614",
                "label": "bnf_d1e99614",
                "type": "#bnf_d1e99614"
            }
        ],
        "#bnf_d1e99637": [
            {
                "id": "bnf_d1e99637",
                "label": "bnf_d1e99637",
                "type": "#bnf_d1e99637"
            }
        ],
        "#bnf_d1e99660": [
            {
                "id": "bnf_d1e99660",
                "label": "bnf_d1e99660",
                "type": "#bnf_d1e99660"
            }
        ],
        "#bnf_d1e99726": [
            {
                "id": "bnf_d1e99726",
                "label": "bnf_d1e99726",
                "type": "#bnf_d1e99726"
            }
        ],
        "#bnf_d1e99749": [
            {
                "id": "bnf_d1e99749",
                "label": "bnf_d1e99749",
                "type": "#bnf_d1e99749"
            }
        ],
        "#bnf_d1e99772": [
            {
                "id": "bnf_d1e99772",
                "label": "bnf_d1e99772",
                "type": "#bnf_d1e99772"
            }
        ],
        "#bnf_d1e99796": [
            {
                "id": "bnf_d1e99796",
                "label": "bnf_d1e99796",
                "type": "#bnf_d1e99796"
            }
        ],
        "#bnf_d1e99863": [
            {
                "id": "bnf_d1e99863",
                "label": "bnf_d1e99863",
                "type": "#bnf_d1e99863"
            }
        ],
        "#bnf_d1e99886": [
            {
                "id": "bnf_d1e99886",
                "label": "bnf_d1e99886",
                "type": "#bnf_d1e99886"
            }
        ],
        "#bnf_d1e99926": [
            {
                "id": "bnf_d1e99926",
                "label": "bnf_d1e99926",
                "type": "#bnf_d1e99926"
            }
        ],
        "#bnf_d1e99949": [
            {
                "id": "bnf_d1e99949",
                "label": "bnf_d1e99949",
                "type": "#bnf_d1e99949"
            }
        ],
        "#bnf_d1e99985": [
            {
                "id": "bnf_d1e99985",
                "label": "bnf_d1e99985",
                "type": "#bnf_d1e99985"
            }
        ],
        "#bnf_d1e53654": [
            {
                "id": "bnf_d1e53654",
                "label": "bnf_d1e53654",
                "type": "#bnf_d1e53654"
            }
        ],
        "#bnf_d1e18111": [
            {
                "id": "bnf_d1e18111",
                "label": "bnf_d1e18111",
                "type": "#bnf_d1e18111"
            }
        ],
        "#bnf_d1e19461": [
            {
                "id": "bnf_d1e19461",
                "label": "bnf_d1e19461",
                "type": "#bnf_d1e19461"
            }
        ],
        "#bnf_d1e21588": [
            {
                "id": "bnf_d1e21588",
                "label": "bnf_d1e21588",
                "type": "#bnf_d1e21588"
            }
        ],
        "#bnf_d1e56961": [
            {
                "id": "bnf_d1e56961",
                "label": "bnf_d1e56961",
                "type": "#bnf_d1e56961"
            }
        ],
        "#bnf_d1e58166": [
            {
                "id": "bnf_d1e58166",
                "label": "bnf_d1e58166",
                "type": "#bnf_d1e58166"
            }
        ],
        "#bnf_d1e77639": [
            {
                "id": "bnf_d1e77639",
                "label": "bnf_d1e77639",
                "type": "#bnf_d1e77639"
            }
        ],
        "#bnf_d1e80257": [
            {
                "id": "bnf_d1e80257",
                "label": "bnf_d1e80257",
                "type": "#bnf_d1e80257"
            }
        ],
        "#bnf_d1e90830": [
            {
                "id": "bnf_d1e90830",
                "label": "bnf_d1e90830",
                "type": "#bnf_d1e90830"
            }
        ],
        "#bnf_d1e90036": [
            {
                "id": "bnf_d1e90036",
                "label": "bnf_d1e90036",
                "type": "#bnf_d1e90036"
            }
        ],
        "#bnf_d1e81849": [
            {
                "id": "bnf_d1e81849",
                "label": "bnf_d1e81849",
                "type": "#bnf_d1e81849"
            }
        ],
        "#bnf_d1e105191": [
            {
                "id": "bnf_d1e105191",
                "label": "bnf_d1e105191",
                "type": "#bnf_d1e105191"
            }
        ],
        "#bnf_d1e15531": [
            {
                "id": "bnf_d1e15531",
                "label": "bnf_d1e15531",
                "type": "#bnf_d1e15531"
            }
        ],
        "#bnf_d1e56135": [
            {
                "id": "bnf_d1e56135",
                "label": "bnf_d1e56135",
                "type": "#bnf_d1e56135"
            }
        ]
    },
    "links": {
        "interaction": [
            {
                "id": "bnf_int_1351",
                "label": "Ibrutinib",
                "type": "interaction"
            }
        ],
        "#drugs": [
            {
                "id": "drugs",
                "label": "Drugs",
                "type": "#drugs"
            }
        ],
        "medicinalForm": [
            {
                "id": "PHP101864",
                "label": "Capsule",
                "type": "medicinalForm"
            }
        ]
    }
}